Subcutaneously administered anti-IL-6 receptor antibody | Patent Number 08580264

US 08580264 B2
Application Number13290366
Publication NumberUS 20120301460 A1
Pendency2 years, 6 days
Filled DateNov 7, 2011
Priority DateNov 8, 2010
Publication DateNov 29, 2012
Expiration DateNov 7, 2030
Inventor/ApplicantsOlivier Alfred Harari
Johannes F. Schmidt
Xiaoping Zhang
Angelika M. Jahreis
Min Bao
Kimio Terao
ExaminesMERTZ, PREMA MARIA
Art Unit1646
Technology Center1600
Assignments
Chugai Pharmaceutical Co. Ltd. Roche
Current
Genentech IncRoche
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.